Shanghai, China · Founded 2022 · In IPO Registration
Developer and researcher of novel RNAi therapies intended to treat chronic diseases. Sirius Therapeutics is based in Shanghai, China and was founded in 2022. Its last reported valuation was $253 million in May 2025. It has raised $214 million.
Last reported valuation
$252.5M
Oct 2026
Priced at
—
Total raised
$214.0M
Last round
—
Cap table — not yet on record
Sirius Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sirius Therapeutics with a free account
·Watch Sirius Therapeutics: the Monday email on marks, rounds and moves
